177 related articles for article (PubMed ID: 15222979)
21. Pantoprazole: a new proton pump inhibitor.
Jungnickel PW
Clin Ther; 2000 Nov; 22(11):1268-93. PubMed ID: 11117653
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage.
Fornai M; Natale G; Colucci R; Tuccori M; Carazzina G; Antonioli L; Baldi S; Lubrano V; Abramo A; Blandizzi C; Del Tacca M
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):79-87. PubMed ID: 16080005
[TBL] [Abstract][Full Text] [Related]
23. Proton pump inhibitors: new drugs and indications.
Mears JM; Kaplan B
Am Fam Physician; 1996 Jan; 53(1):285-92. PubMed ID: 8546054
[TBL] [Abstract][Full Text] [Related]
24. Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.
Uygun A; Kadayifçi A; Yeşilova Z; Savaş MC; Ateş Y; Karslioğlu Y; Ciğerim M; Bağci S; Dağalp K
Turk J Gastroenterol; 2004 Dec; 15(4):219-24. PubMed ID: 16249974
[TBL] [Abstract][Full Text] [Related]
25. [Proton pump inhibitors: Pantoprazole].
Takeuchi K; Hase S
Nihon Rinsho; 2002 Feb; 60 Suppl 2():655-60. PubMed ID: 11979865
[No Abstract] [Full Text] [Related]
26. Reversible edema in a male patient taking parenteral pantoprazole infusion for pyloric stenosis.
Sennaroglu E; Karakan S; Kayatas M; Akdur S; Genc H; Karakan T; Ucler R; Ozisler C; Urun Y
Dig Dis Sci; 2006 Jan; 51(1):121-2. PubMed ID: 16416223
[No Abstract] [Full Text] [Related]
27. The proton-pump inhibitors: similarities and differences.
Horn J
Clin Ther; 2000 Mar; 22(3):266-80; discussion 265. PubMed ID: 10963283
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease.
Castell D; Bagin R; Goldlust B; Major J; Hepburn B
Aliment Pharmacol Ther; 2005 Jun; 21(12):1467-74. PubMed ID: 15948814
[TBL] [Abstract][Full Text] [Related]
29. Pantoprazole.
Poole P
Am J Health Syst Pharm; 2001 Jun; 58(11):999-1008. PubMed ID: 11402494
[TBL] [Abstract][Full Text] [Related]
30. Growth inhibitory and bactericidal activities of lansoprazole compared with those of omeprazole and pantoprazole against Helicobacter pylori.
Nakao M; Malfertheiner P
Helicobacter; 1998 Mar; 3(1):21-7. PubMed ID: 9546114
[TBL] [Abstract][Full Text] [Related]
31. Oral and intravenous dosage forms of pantoprazole are equivalent in their ability to suppress gastric acid secretion in patients with gastroesophageal reflux disease.
Metz DC; Pratha V; Martin P; Paul J; Maton PN; Lew E; Pisegna JR
Am J Gastroenterol; 2000 Mar; 95(3):626-33. PubMed ID: 10710049
[TBL] [Abstract][Full Text] [Related]
32. The inhibitory effects of H+ K+ ATPase inhibitors on human neutrophils in vitro: restoration by a K+ ionophore.
Martins de Oliveira R; Antunes E; Pedrazzoli J; Gambero A
Inflamm Res; 2007 Mar; 56(3):105-11. PubMed ID: 17406807
[TBL] [Abstract][Full Text] [Related]
33. Effect of pantoprazole administered subcutaneously on the healing of sutured gastric incisions in rats.
Bonin EA; Campos AC; Coelho JC; Matias JE; Malafaia O; Jonasson TH
Eur Surg Res; 2005; 37(4):250-6. PubMed ID: 16260877
[TBL] [Abstract][Full Text] [Related]
34. Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: a U.S. multicenter randomized, double-blind study.
Jensen DM; Pace SC; Soffer E; Comer GM;
Am J Gastroenterol; 2006 Sep; 101(9):1991-9; quiz 2170. PubMed ID: 16968504
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and tolerance of pantoprazole, a proton pump inhibitor after single and multiple oral doses in healthy Japanese volunteers.
Tanaka M; Yamazaki H; Ryokawa Y; Hakusui H; Nakamichi N; Sekino H
Int J Clin Pharmacol Ther; 1996 Oct; 34(10):415-9. PubMed ID: 8897077
[TBL] [Abstract][Full Text] [Related]
36. Lack of pantoprazole drug interactions in man: an updated review.
Steinijans VW; Huber R; Hartmann M; Zech K; Bliesath H; Wurst W; Radtke HW
Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S31-50. PubMed ID: 8793602
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease.
van Zyl J; van Rensburg C; Vieweg W; Fischer R
Digestion; 2004; 70(1):61-9. PubMed ID: 15297779
[TBL] [Abstract][Full Text] [Related]
38. ["Mirror, mirror on the wall which is the best proton pump inhibitor of all?"].
Labenz J; Petersen KU; Rösch W; Koelz HR
Z Gastroenterol; 2003 Nov; 41(11):1123. PubMed ID: 14648385
[No Abstract] [Full Text] [Related]
39. A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradication.
Hsu PI; Lai KH; Lin CK; Chen WC; Yu HC; Cheng JS; Tsay FW; Wu CJ; Lo CC; Tseng HH; Yamaoka Y; Chen JL; Lo GH
Am J Gastroenterol; 2005 Nov; 100(11):2387-92. PubMed ID: 16279889
[TBL] [Abstract][Full Text] [Related]
40. [Recent topics on important drugs for H. pylori eradication: Pantoprazole sodium].
Okazaki K; Mori S; Tahashi K
Nihon Rinsho; 2005 Nov; 63 Suppl 11():354-60. PubMed ID: 16363559
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
